Skip to main content

Advertisement

SpringerLink
Log in

Methodological remarks concerning a recent meta-analysis on XPG Asp1104His and XPF Arg415Gln polymorphisms and breast cancer risk

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ding DP, He XF, Zhang Y (2011) Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies. Breast Cancer Res Treat 129:203–209

    Article  PubMed  Google Scholar 

  2. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, Liu-Mares W, Hu JJ (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29:2132–2138

    Article  PubMed  CAS  Google Scholar 

  3. Kavvoura FK, Ioannidis JP (2008) Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 123:1–14

    Article  PubMed  Google Scholar 

  4. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  5. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  6. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM (2005) Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:336–342

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

All authors declared that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China

    Qiliu Peng, Xianjun Lao, Xue Qin & Shan Li

  2. Department of Medicine Research, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

    Ruoling Li

Authors
  1. Qiliu Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xianjun Lao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ruoling Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xue Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xue Qin or Shan Li.

Additional information

Qiliu Peng and Xianjun Lao contributed equally to this study and should be considered as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peng, Q., Lao, X., Li, R. et al. Methodological remarks concerning a recent meta-analysis on XPG Asp1104His and XPF Arg415Gln polymorphisms and breast cancer risk. Breast Cancer Res Treat 139, 617–618 (2013). https://doi.org/10.1007/s10549-013-2526-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2526-x

Keywords

Search

Navigation